Merck & Co., Inc. Quarterly Liabilities and Equity in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Merck & Co., Inc. quarterly Liabilities and Equity history and growth rate from Q1 2010 to Q3 2024.
  • Merck & Co., Inc. Liabilities and Equity for the quarter ending September 30, 2024 was $118B, a 10.1% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $118B +$10.8B +10.1% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $113B +$8.16B +7.81% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $106B -$1.95B -1.81% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $107B -$2.49B -2.28% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $107B -$354M -0.33% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $104B -$2.63B -2.45% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $108B +$1.13B +1.06% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $109B +$3.47B +3.28% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $107B +$13.6B +14.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $107B +$16.4B +18.1% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $107B +$15.8B +17.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $106B +$14.1B +15.4% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $93.5B +$3.69B +4.11% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $90.7B +$73M +0.08% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $90.8B +$5.93B +6.99% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $91.6B +$7.19B +8.52% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $89.8B +$6.47B +7.76% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $90.6B +$6.65B +7.92% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $84.9B +$2.56B +3.11% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $84.4B +$1.76B +2.13% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $83.3B -$1.8B -2.11% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $84B -$1.08B -1.26% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $82.4B -$3.69B -4.29% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $82.6B -$5.24B -5.96% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $85.1B -$6.55B -7.14% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $85B -$7.76B -8.37% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $86B -$10.5B -10.9% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $87.9B -$7.51B -7.87% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $91.7B -$6.66B -6.77% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $92.8B -$3.67B -3.81% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $96.6B -$2.19B -2.22% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $95.4B -$6.3B -6.2% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $98.3B -$2.9B -2.86% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $96.5B -$6.11B -5.95% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $98.8B -$9.59B -8.85% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $102B +$3.51B +3.58% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $101B -$576M -0.57% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $103B +$4.72B +4.83% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $108B -$115M -0.11% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $98.2B -$7.48B -7.08% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $102B -$4.61B -4.33% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $97.9B -$9.02B -8.44% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $108B +$2.26B +2.13% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $106B -$487M -0.46% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $106B +$118M +0.11% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $107B +$1.35B +1.28% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $106B +$691M +0.66% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $106B +$1B +0.96% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $106B -$233M -0.22% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $106B -$670M -0.63% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $106B -$356M -0.34% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $105B -$653M -0.62% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $107B -$1.31B -1.21% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $106B +$24.5M +0.02% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $106B -$5.73B -5.13% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $106B Dec 31, 2010 10-K 2012-02-28
Q3 2010 $108B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $106B Jun 30, 2010 10-Q 2010-08-06
Q1 2010 $112B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.